Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
J Clin Oncol
; 10(6): 984-9, 1992 Jun.
Article
em En
| MEDLINE
| ID: mdl-1588379
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Hidrocortisona
/
Adenocarcinoma
/
Aminoglutetimida
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
1992
Tipo de documento:
Article